DHRS2 and cancer: Furthermore, one member of the superfamily of short-chain dehydrogenases/reductases (SDR) was found to be overexpressed in cancer (DHRS2 or Hep27, Supplementary Table S1), SDR catalyzes the NADPH-dependent reduction of dicarbonyl compounds [31].